Overall architecture of the OST
OST was purified from yeast strain LY510 (Methods). Purified OST is mainly of isoform Ost3, as Ost6 was barely detectable (Extended Data Fig. 1 ). We determined a 3.5 Å resolution cryo-electron microscopy (cryo-EM) three-dimensional map and built an atomic model ( Fig.  1a -c, Extended Data Figs 2, 3, Extended Data Table 1 , Supplementary Videos 1, 2). The model contains 4 out of the 5 lumenal domains, 26 out of the 28 transmembrane helices (TMHs), 3 N-glycans at Asn336 of Ost1p, Asn60 of Wbp1p, and Asn539 of Stt3p, and 8 phospholipids.
All five OST soluble domains are in the ER lumen ( Fig. 1b, c) . The four well-resolved soluble domains are from Stt3, Ost1, Wbp1 and Swp1. The fifth domain is from Ost3, which has TRX activity and interacts with the nascent peptide 17 . This domain is visible in one 3D class, indicating flexibility probably owing to the absence of the acceptor peptide (Extended Data Fig. 4 ). These domains are arranged in an intermediate layer proximal to the membrane and a top layer distal to the membrane. In the intermediate layer, the lumenal domain of Stt3 binds tightly with the middle domain of Wbp1 and NTD2 of Ost1. By contrast, the three domains in the top layer, NTD of Wbp1, NTD1 of Ost1, and NTD of Swp1, are packed loosely.
Notably, the transmembrane domain of the OST complex has a triangular shape in which Stt3 is in the centre, surrounded by all other subunits (Extended Data Fig. 5a-c) . TMH2-TMH4 of Ost3 pack against TMH10-TMH11 and TMH13 of Stt3, forming the top angle. At the lower right angle, TMH1-TMH3 of Ost2 directly interacts with TMH5 and TMH7-TMH8 of Stt3, and TMH1 of Wbp1 and TMH1-TMH3 of Swp1 are further out, interacting with Ost2. TMH1 of Ost1 and TMH1-THM2 of Ost5 are loosely organized and constitute the lower left angle. The two missing TMHs, TMH9 of Stt3 and TMH1 of Ost3, surround the lipid-linked oligosaccharide (LLO) docking site and are presumably flexible in the absence of the donor.
The structure of Stt3
The catalytic subunit Stt3 comprises 13 TMHs, a lumenal domain, and an α -helical accessory domain that is formed by external loop 1 (EL1) ( Fig. 2a, b) . The 13-TMH topology is consistent with a published characterization of yeast and mouse Stt3 and is similar to the prokaryotic homologues 13, 27 . The Stt3 lumenal domain is a mixed α /β -fold, similar to the prokaryotic counterparts [10] [11] [12] [13] 28 , but it is different from the NMR structure of the yeast Stt3 that was derived from proteins refolded in N-glycosylation is a ubiquitous modification of eukaryotic secretory and membrane-bound proteins; about 90% of glycoproteins are N-glycosylated. The reaction is catalysed by an eight-protein oligosaccharyltransferase (OST) complex that is embedded in the endoplasmic reticulum membrane. Our understanding of eukaryotic protein N-glycosylation has been limited owing to the lack of high-resolution structures. Here we report a 3.5 Å resolution cryo-electron microscopy structure of the Saccharomyces cerevisiae OST complex, revealing the structures of subunits Ost1-Ost5, Stt3, Wbp1 and Swp1. We found that seven phospholipids mediate many of the inter-subunit interactions, and an Stt3 N-glycan mediates interactions with Wbp1 and Swp1 in the lumen. Ost3 was found to mediate the OST-Sec61 translocon interface, funnelling the acceptor peptide towards the OST catalytic site as the nascent peptide emerges from the translocon. The structure provides insights into co-translational protein N-glycosylation, and may facilitate the development of small-molecule inhibitors that target this process.
the presence of the denaturing sodium dodecyl sulfate 29 . The structural conservation between Stt3 and prokaryotic enzymes is remarkable, considering their approximately 20% sequence identity. The bacterial enzymes have an extended acceptor sequon of DXNXS/T 30 . The − 2 position D is stabilized by R331 in the PglB crystal structure 13 . PglB R331 is replaced by D362 in yeast Stt3, explaining the shorter eukaryotic sequon of NXS/T. Notably, the yeast Stt3 has a carboxyl terminal extension (CTE) that mediates the interaction between Wbp1 and Swp1 ( Fig. 2a , c, Extended Data Fig. 3 ). The Stt3 CTE is apparently a eukaryotespecific feature as it is absent in prokaryotes (Extended Data Figs 6, 7) . The CTE of the metazoan STT3A is shorter than that of the STT3B. It would be interesting to investigate whether the longer CTE endows the STT3B isoform with the capacity to glycosylate post-translationally the extreme C-terminal acceptor sites of the nascent polypeptides that have been skipped by the STT3A isoform 31 .
There is a horizontal substrate-binding groove in Stt3 between the transmembrane domain and lumenal domain. The roof of the groove is lined by the highly conserved glycosylation-sequon-binding WWD motif. Compared with the periplasmic domain of PglB in complex with a peptide substrate, the Stt3 lumenal domain is shifted outwards by 3 Å, leading to a widened groove ( Fig. 2b) , which may facilitate substrate binding. Relative to PglB, TMH1 and TMH13 in Stt3 move away from each other to accommodate the sole TMH of Ost4; in this regard, Ost4 may be considered as an integral part of Stt3 (Extended Data Fig. 5c ). TMH8-TMH9 slide by 25 Å towards the LLO-binding surface, leaving a space for Ost2 TMH1-TMH2. Stt3 residues that are expected to co ordinate Mn 2+ and LLO, such as Asp47, Asp166, Glu168, Trp208 and Arg404, are superimposable with their respective counterparts in PglB (Fig. 2b , Extended Data Fig. 6b) .
The Stt3 N-glycan in the Asn539-Asn540-Asn541 sequon interacts with Asp320, Tyr322 and Arg349 of Wbp1 and with His182 in the linker loop of Swp1 ( Fig. 2a, d ), suggesting that the glycan stabilizes the complex by gluing these subunits together. A previous study showed that the Asn539Gln mutation is lethal, and the Thr541Ala mutation is severely temperature-sensitive 32 .
Ordered phospholipids mediate OST complex assembly
The eight OST subunits can be grouped into three subcomplexes: Ost1-Ost5, Ost2-Swp1-Wbp1 and Stt3-Ost3-Ost4 ( Fig. 3a, b ). This architecture is consistent with a previous cross-linking study 33 . The interfaces among the three subcomplexes in the membrane region are loose, with only a few protein-protein interactions between Ost2 and Stt3. We identified seven phospholipids (PL1-PL7) at the interfaces of these subcomplexes, and an eighth phospholipid (PL8) at the donor-binding site in Stt3, to be described below; each of these lipid molecules has well-defined electron densities ( Fig. 3c, d , Extended Data Fig. 3 ). PL1-PL3 fill a 15 Å gap at the interface between Stt3 and Ost1-Ost5. Their hydrophilic groups interact with Trp241, Gln250, Glu252, Asp301, Tyr303 and Tyr409 of Ost1, Arg112 and Asn113 of Stt3, and Tyr85 of Ost5. The lipid tails contact hydrophobic residues in TMH1-TMH2 of Stt3 and TMH2 of Ost5 ( Fig. 3c ). PL4-PL5 mediate the interaction between Stt3 and Ost2-Swp1 ( Fig. 3d ). Their tails interact with hydrophobic residues of TMH3 of Ost2, TMH2-TMH3 of Swp1, TMH5 and EL1 of Stt3, whereas the phosphate groups directly hydrogen bond to the side chains of Asn380, Asp381 and Arg385 of Wbp1. PL6-PL7 stabilize the interface of Stt3 and Ost2-Swp1. Many of these phospholipid-interacting residues are conserved (Extended Data Figs 7-9). Lipids are known to have important roles in membrane enzyme complexes 34, 35 and can mediate transient multimerization of membrane proteins 36 . A published cryo-EM structure showed that lipids are involved in the assembly of the heterotetrameric γ -secretase 37 .
Structures of the noncatalytic subunits
In the Ost1-Ost5 subcomplex, the Ost1 contains two lumenal domains, NTD1 and NTD2; both are composed of a larger seven-stranded β -sheet with a smaller, four-stranded β -sheet attached at each end, and on the same face of, the larger sheet. NTD1 and NTD2 are superimposable with a root mean square deviation (r.m.s.d.) value of 2.8 Å, despite their 9% sequence identity ( Fig. 4a, b ). This fold is similar to the noncatalytic domain of leukotriene A4 aminopeptidase (also known as leukotriene A4 hydrolase) (r.m.s.d. value of 2.9 Å). Because Ost1 can bind the glycosylated, but not the unglycosylated, sequon 22 , NTD1 and NTD2 may function to prevent the glycosylated peptide from sliding back to the catalytic site. Perhaps related to this function, the Ost1 NTD2 has an extra conserved hydrophobic motif (relative to NTD1) that specifically binds to the Stt3 catalytic domain (Fig. 4b , Extended Data Fig. 8 ). Ost5 seems to be an accessary factor of Ost1, as its two TMHs pack against the sole TMH of Ost1, and the N-terminal lumenal 20 residues of Ost5 latches onto the Ost1 NTD2, positioning Ost1 NTD2 for an interaction with Stt3 (Figs 3, 4 ). 
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The Ost2-Swp1-Wbp1 subcomplex contains three soluble domains: the NTD and middle domain of Wbp1 and NTD of Swp1 (Fig. 4c ). The NTD and linker loop of Swp1 interact extensively with the NTD and middle domain of Wbp1. In the membrane region, four TMHs of Ost2 and three TMHs of Swp1 surround the sole TMH of Wbp1 (Fig. 4c ). The functions of these domains are largely unknown, except that Wbp1 contains a GIFT domain (for the bacterial gliding protein GldD, intraflagellar transport (IFT)) and therefore may be involved in LLO binding 38 . The Wbp1 NTD is superimposable with the NTD of IFT52 ( Fig. 4d ; r.m.s.d. of 2.9 Å), and that the middle domain of Wbp1 is similar to amylase domain N ( Fig. 4e ; r.m.s.d. of 2.7 Å), which has a pullulan-binding site. The Swp1 NTD resembles myeloid differentiation factor 1 (MD-1), a lipopolysaccharide (LPS)-and sugar-binding co-receptor of the RP105-MD-1 Toll-like receptor complex ( Fig. 4f ; r.m.s.d. of 3.5 Å). These results suggest that both Wbp1 and Swp1 are involved in recruiting LLO. Indeed, Wbp1 and its mammalian homologue OST48 were shown to cross-link with LLO 21, 39 .
In the Stt3-Ost4-Ost3 subcomplex, Ost4 stabilizes the Stt3 structure (Extended Data Fig. 5a, b ). Ost3 has three TMHs that interact with TMH10, TMH11 and TMH13 of Stt3. TMH2 of Ost3 and TMH6 and TMH11 of Stt3 form a vertical groove that may function as LLO docking site ( Fig. 5a, b ). Consistent with this possibility, W208 at the upper half of the groove, close to the catalytic centre (Figs 2b, 5c), was previously shown to be lethal when mutated to alanine in Stt3 40 . The corresponding Trp215Ala mutation in AglB reduced the activity 11 , and the PglB equivalent residue Tyr196 directly interact with LLO 12 . The lower half of this groove is lined with numerous hydrophobic residues and is occupied by phospholipid PL8 in our structure ( Fig. 5c ). Superposition of the structure of the PglB bound to the acceptor peptide and donor analogue with the Stt3 structure showed that the acceptor fits right into the putative active site and LLO analogue fits in potential LLO-docking vertical groove in Stt3 (Figs 2b, 5c ).
The LLO entry route and lateral helix of Ost2
The EL5 loop of PglB is disordered in the absence of the donor, but becomes ordered when both donor and acceptor substrates are present 12, 13, 41 (Fig. 5d ). It was previously proposed that EL5 disordering allows the donor to diffuse under it into the catalytic site 12 . Eukaryotic LLO is much larger, both in the transmembrane dolichol region and the lumenal oligosaccharide region: the yeast dolichol contains 14-18 repeating isoprene units, twice that of bacterial LLO 42 , and the yeast oligosaccharide contains 14 sugars compared with the 7-sugar bacterial oligosaccharide. As such, the donor docking and recognition mechanisms of PglB and eukaryotic OST are probably different. Indeed, as described earlier, there is a large membrane-embedded pocket inside OST formed by TMH2 of Ost3 and TMH6, TMH8 and TMH11 of Stt3 (Fig. 5a, b ). The disordered EL5 and TMH9 of Stt3 and TMH1 of Ost3 enlarge the donor-binding pocket. Furthermore, the Stt3 TMHs 8 and 9 slide towards the LLO-binding surface by about 25 Å relative to that of PglB (as described earlier) and form a lumenally unobstructed 10 Å-wide gap. The yeast oligosaccharide is probably too large to dive under the disordered EL5 to enter the catalytic site. We suggest that yeast LLO enters the catalytic site via the 10 Å gap between TMH8 and TMH9 in Stt3. This route has the added advantage of being closer to the potential LLO recruiters Wbp1 and Swp1 (Fig. 5a, b) . Consistent with two distinct LLO access routes between OST and PglB, the PglB TMH8 and TMH9 are far from the LLO-binding site, tightly packed against other TMHs, and do not change their location whether the LLO is present or not (Fig. 5d, Extended Data Fig. 5c ).
Ost2 has a cytoplasmic lateral α -helix (Figs 1c, 5a, b) . The lateral α -helix stabilizes the Stt3 TMH8-TMH9 hairpin, and interacts with Swp1 TMH3 and WBP1 TMH1, both of which extend towards their respective lumenal domains. Because the Stt3 TMH9 is largely disordered in the absence of donor, binding of dolichol will probably cause ordering of TMH9, which may be sensed by and communicated through the lateral α -helix to the lumenal domains of Swp1 and Wbp1 via their respective TMH3 and TMH1. Because Swp1 and Wbp1 are involved in oligosaccharide binding, such a relay mechanism via the lateral α -helix may lead to coordination between the binding of dolichol in the membrane and OS binding in the lumen.
Ost3 mediates the OST-translocon interface
OST and the Sec61 complex simultaneously bind to ribosomes in vitro 43 . Published cryo-electron tomographic studies showed the relative positions of mammalian translocons and OSTs bound to the ribosomes 24, 26 . However, the detailed interface-that is, which subunits mediate the OST-translocon interaction-was unclear. We docked the yeast OST atomic model into the cryo-electron tomogram and found that it fit well into the mammalian OST density except for two extra densities (Fig. 6a ). These densities are likely to belong to the NTD of mammalian ribophorin II and CTD of ribophorin I, because only ribophorin I and II contain the extra sizable sequences (Extended Data Figs 8, 9 ). We further docked the crystal structure of a mammalian Sec61 into the tomogram and identified Ost3 as mediating the OST interaction with the translocon (Supplementary Video 3) . Specifically, the Ost3 TMH3-TMH4 pack tightly with TMH1 of Sec61α , TMH2 of Sec61β and the sole TMH of Sec61γ (Fig. 6b ). This finding explains why the two yeast OST isoforms are defined by the presence of either Ost3 or Ost6: they interact with the Sec61 and Ssh1 translocons, respectively 15 . Our finding is also consistent with the finding that that DC2 and KCP2 mediate the interaction between the human OST complex and translocon 44 .
On the basis of these observations, we proposed a pathway for the nascent peptide during the co-translational N-glycosylation (Fig. 6b) . Specifically, the nascent peptide emerging from the Sec61 translocon is first captured by the lumenal TRX of Ost3 and then is threaded through the Stt3 catalytic site for N-glycosylation. Finally, the glycosylated peptide is stabilized by the two lumenal domains of Ost1, perhaps to prevent its backtracking.
Conclusion
Our cryo-EM study of the eukaryotic OST complex provides the atomic models of all eight component membrane proteins, reveals how these subunits assemble into a functional complex and suggests functions for 
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MethODS
Purification of the OST complex. The OST complex was purified from the yeast strain LY500 as previously described 23 . In brief, cells were lysed by French press at 103,000 kPa, and microsomes were collected by centrifugation. The membrane pellet was then resuspended and dissolved in buffer containing 10% glycerol, 20 mM Tris-HCl (pH 7.4), 1.5% digitonin, 0.5 M NaCl, 1 Mm MgCl 2 , 1 mM MnCl 2 , 1 mM EDTA and 1 mM phenylmethylsulfonyl fluoride. After incubation for 30 min, the mixture was centrifuged for 30 min at 120,000 g, and the clarified supernatant was mixed with pre-washed anti-Flag (M2) affinity gel at 4 °C overnight with shaking. The affinity gel was collected by centrifugation and washed three times in buffer A containing 0.2% digitonin, 150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 1 mM MgCl 2 , 1 mM MnCl 2 . Finally, the OST complex was eluted with buffer A containing 0.15 mg ml −1 3× Flag peptide, and further purified in a Superose 6 10/300 gel filtration column in buffer A. The quality of the final sample was confirmed by SDS-PAGE gel. To examine the presence of Ost3 and Ost6 in the purified complex, three bands around 30 kDa in the SDS-PAGE were cut out and identified by tryptic digestion and mass spectrometry. Cryo-electron microscopy. Aliquots of 3 μ l of purified OST at a concentration of 5 mg ml −1 were placed on glow-discharged holey carbon grids (Quantifoil Au R1.2/1.3, 300 mesh) and flash-frozen in liquid ethane using an FEI Vitrobot Mark IV. The grids were then loaded into an FEI Titan Krios electron microscope operated at a high tension of 300 kV and images were collected automatically with EPU (FEI) at a nominal magnification of 130,000× in EFTEM mode and a pixel size of 1.088 Å per pixel with defocus values from − 1.5 to − 2.5 μ m. A Gatan K2 Summit direct electron detector was used under super resolution counting mode for image recording. A BioQuantum energy filter installed in front of the K2 detector was operated in zero-energy-loss mode with an energy slit width of 20 eV. The dose rate was 10 electrons per Å 2 per second, and the total exposure time was 6 s. The total dose was divided into a 30-frame movie so each frame was exposed for 0.2 s. Image processing. About 4,000 raw movie micrographs were collected and motion-corrected using the program MotionCorr 2.0 47 . Contrast transfer function parameters of each aligned micrograph were calculated using GCTF 48 . All the remaining steps, including particle auto selection, 2D classification, 3D classification, 3D refinement and density map post-processing, were performed using RELION 2.0 49 . Templates for automatic picking were generated from 2D averages of about 10,000 manually picked particles. A total of 823,255 particles were picked automatically. 2D classification was then performed and particles in the classes with features unrecognizable by visual inspection were removed. A total of 369,452 particles was used for further 3D classification, and 282,202 particles were selected for further 3D refinement and post-processing, resulting in the 3.5 Å 3D density map. The resolution of the map was estimated by the gold-standard Fourier shell correlation at a correlation cut-off value of 0.143. Structural modelling, refinement and validation. The initial models of Stt3, the soluble domain of Ost1, and the NTD of Wbp1 were generated, respectively, from the crystal structures of Archaeoglobus fulgidus oligosaccharyltransferase (PDB code 3WAK), leukotriene A4 hydrolase (PDB code 5NI2), and IFT52 (PDB code 5FMS) using the online server SWISSMODEL (https://swissmodel.expasy. org). The model of Stt3 was split into a transmembrane domain and a periplasmic domain. These models were docked into the 3.5 Å electron microscopy map in COOT and Chimera 50, 51 . All other subunits of OST were manually built into the remaining density in the program COOT. Sequence assignment was guided by bulky residues such as Phe, Tyr, Trp and Arg. The entire OST model was then refined by rigid-body refinement of individual chains in the PHENIX program and subsequently was adjusted manually in COOT 52 . There were densities for eight lipid molecules, each with well-defined densities for a head group and two tails. However, the precise chemical nature of the head group is unclear owing to the limited resolution. We modelled all lipids as a phosphatidylcholine, which is the most common lipid (approximately 60% phospholipid) in the ER membrane. The final model was also cross-validated as described before 53 . Using the PDB tools in Phenix, to the coordinates of the final model was first randomly added 0.1 Å noise, and then on this noise-added model was performed one round of refinement against the first half-map (half1) that was produced during 3D refinement by RELION. We then correlated the refined model with the 3D maps of the two half-maps (half1 and half2) to produce two Fourier shell correlation (FSC) curves: FSC work (model versus half1 map) and FSC free (model versus half2 map). Additionally, we generated a third FSC curve using the final model and the final 3.5 Å-resolution density map produced from all particles. The general agreement of these curves was taken as an indication that the model was not over-fitted. Finally, the atomic model was validated using MolProbity 54 . Structural figures were prepared in Chimera and PyMOL (https://pymol.org/2/). Data availability. The cryo-EM 3D map of the S. cerevisiae OST complex has been deposited at the Electron Microscopy Data Bank (EMDB) database with accession code EMD-7336. The corresponding atomic model was deposited at the RCSB Protein Data Bank (PDB) database with accession code 6C26. Corresponding author(s): Huilin Li Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design 1. Sample size
Describe how sample size was determined.
Cryo-EM dataset was collected during two 3-day sessions, resulting to number of particles for the desired resolution.
Data exclusions
Describe any data exclusions.
"Bad" raw particles were excluded after 2D and 3D classifications, per standard image processing practice.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Replicability resides in the large number of particles used to derived at the final 3D map. The reliability and the resolution is measured by the Gold standard Fourier shell correlation.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The raw particles were randomly selected by computer program (RELIONS)
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were blinded to the data collection and analysis. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
